Anxiety and depression as aspects of influence on the quality of life in patients with lymphoproliferative diseases
|
Full Text:
Subscribers Only
|
Suggested citation:
Sarvarova AF, Khvostanceva YuR, Kuz'mina SV. [Anxiety and depression as aspects of influence on the quality of life in patients with lymphoproliferative diseases]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2024;(3):75-80. Russian
In a pilot one-stage study to study the prevalence of anxiety-affective spectrum disorders and their impact on quality of life and adaptability in patients with diagnosed diseases of Hodgkin's lymphoma, non-Hodgkin's lymphoma and a group of other diseases including gastric lymphoma and T- and B-cell lymphoma, 95 patients (52 women and 43 men). According to a number of domestic and foreign studies, the prevalence of anxiety and/or depression among patients with cancer is high, which affects a decrease in the quality of life. At the same time, the results of the study showed that patients with lymphoproliferative diseases are characterized by a slight decrease in their quality of life, a high level of life satisfaction, and good stress resistance to workloads. The obtained data make it possible to emphasize the heterogeneity of the prevalence and severity of anxiety-affective symptoms in patients with various types of oncological diseases.
Keywords lymphoproliferative diseases; anxiety; depression; quality of life
1. Kamolova FSh, Zeinalova PA, Azizyan RI, et al. [Lymphoproliferative disorders affecting organs of the head and neck]. Opukholi golovy i shei [Head and Neck Tumors]. 2022;12(2):12–24. DOI: https://doi.org/10.17650/2222-1468-2022-12-2-12-24 2. Sostoyanie onkologicheskoi pomoshchi naseleniyu v Rossii v 2022 godu. AD Kaprin, VV Starinskii, AO Shakhzadova, editors. Moscow: MNIOI im. PA Gertsena − filial FGBU “NMITs radiologii” Minzdrava Rossii; 2022. 239 p. 3. Flechtner H, Bottomley A. Fatigue and quality of life: lesson from the real word. Oncologist. 2003;8(1):5–9. DOI: https://doi.org/10.1634/theoncologist.8-suppl_1-5 4. Levin OS, Chimagomedova ASh, Aref'eva AP. Trevozhnye narusheniya u bol'nykh s onkologicheskimi zabolevaniyami: vliyanie na techenie onkologicheskogo protsessa i vozmozhnosti korrektsii. Rossijskij medicinskij zhurnal. 2018;26(12-1):25–31. 5. Chulkova VA, Moiseenko VM. Psikhologicheskie problemy v onkologii. Prakticheskaya onkologiya. 2009;10(3):151–7. 6. Teregulova DR, Bakirov BA, Akhmadeeva LR. [An impact of affective and cognitive impairment on the quality of life in patients with lymphoproliferative diseases]. Zh Nevrol Psikhiatr Im SS Korsakova. 2019;119(4):5–8. DOI: https://doi.org/10.17116/jnevro20191190415 7. Ivanov SV. [Depressive disorders in oncology (review)]. Zh Nevrol Psikhiatr Im SS Korsakova. 2012;112(11-2):104–9. 8. Shimkin M. Contrary to nature. Washington DC: US Department of Health and Human Services, Public Health Service; 1977. NIH Publication No 76–729. 9. Nenarokomov AYu, Speranskii DL, Arevshatov EV, Mudryi AYu. Sovremennaya kontseptsiya issledovaniya kachestva zhizni v onkologii [A modern concept quality of life reseach in oncology]. Fundamental'nye issledovaniya. 2012;(2-2):421–5. 10. Sidorov PI. [Mental health service]. Ekologiya cheloveka [Human ecology]. 2014;21(8):44–56. 11. Vodop'yanova N.E. Psikhodiagnostika stressa. Saint-Petersburg: Piter; 2009. р. 41–3.
Article Metrics
Metrics powered by PLOS ALM